Clinical characteristics of patients with bone sarcoidosis

Abstract Objective To assess the clinical features, diagnosis, and treatment of bone sarcoidosis in the United States. Methods Patients with bone sarcoidosis were identified and matched to sarcoidosis patients based on race, gender, and age. Detailed characteristics were obtained by medical record r...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in arthritis and rheumatism 2017-08, Vol.47 (1), p.143-148
Main Authors: Zhou, Ying, Lower, Elyse E, Li, Huiping, Farhey, Yolanda, Baughman, Robert P
Format: Article
Language:English
Subjects:
Adult
Aged
Anemia - complications
Antirheumatic Agents - therapeutic use
Bone Diseases - diagnosis
Bone Diseases - physiopathology
Bone Diseases - therapy
Bone marrow
Bone Marrow Diseases - diagnosis
Bone Marrow Diseases - drug therapy
Bone Marrow Diseases - physiopathology
Bone sarcoidosis
Case-Control Studies
Disease Progression
Female
Humans
Infliximab
Infliximab - therapeutic use
Magnetic Resonance Imaging
Male
Methotrexate
Middle Aged
Positron Emission Tomography Computed Tomography
Retrospective Studies
Rheumatology
Sarcoidosis - diagnosis
Sarcoidosis - drug therapy
Sarcoidosis - physiopathology
Spine
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Objective To assess the clinical features, diagnosis, and treatment of bone sarcoidosis in the United States. Methods Patients with bone sarcoidosis were identified and matched to sarcoidosis patients based on race, gender, and age. Detailed characteristics were obtained by medical record review. Results A total of 64 patients with bone sarcoidosis were enrolled in the study. The female: male ratio was 1.46: 1 and the White to Black ratio was 3: 1. Thirty-eight (59.4%) of 64 patients had bone symptoms. Compared to matched cases, bone sarcoidosis patients have more multi organ involvement and higher incidence with liver, spleen and extra thoracic lymph node involvement than controls (P
ISSN:0049-0172
1532-866X
DOI:10.1016/j.semarthrit.2017.02.004